The Business of Autism: Private Equity, Medicaid & the Cost of Care

This episode is brought to you by Semafor Healthcare.

Delivered weekly from David Lim, Semafor Healthcare connects the dots between decisions in government, business, and technology to reveal how they impact the future of healthcare. Each edition will provide the analysis you need to understand and stay ahead of a rapidly changing landscape. Subscribe for free.

Health Affairs Publishing's Jeff Byers welcomes Dan Arnold of Brown University to discuss the rapid growth of Medicaid spending on autism treatment and the expanding role of private equity-backed providers in the applied behavior analysis (ABA) therapy market.

He explores the drivers behind rising costs, emerging concerns about care quality and fraud, and the challenge of balancing oversight with continued access to services for families.

Related Links:

• The Business Of Autism Treatment: Private Equity Implications For State Medicaid Programs (Health Affairs Forefront)

Sign up for Health Affairs' free newsletter to catch up on our new articles, podcasts, and events.

Subscribe to Semafor Healthcare for free.